{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T02:19:19Z","timestamp":1772677159150,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1124\/mol.110.068478","type":"journal-article","created":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T03:30:57Z","timestamp":1289964657000},"page":"340-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Progesterone Receptor Membrane Component 1 Inhibits the Activity of Drug-Metabolizing Cytochromes P450 and Binds to Cytochrome P450 Reductase"],"prefix":"10.1016","volume":"79","author":[{"given":"Elzbieta","family":"Szczesna-Skorupa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byron","family":"Kemper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.110.068478_bib1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/jpet.109.164210","article-title":"Progesterone receptor membrane component 1 (Pgrmc1): a heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule","volume":"333","author":"Ahmed","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.110.068478_bib2","doi-asserted-by":"crossref","first-page":"18726","DOI":"10.1016\/S0021-9258(17)46690-7","article-title":"The amino-terminal 29 amino acids of cytochrome P450 2C1 are sufficient for retention in the endoplasmic reticulum","volume":"268","author":"Ahn","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.068478_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0163-7258(03)00031-7","article-title":"Organization of multiple cytochrome P450s with NADPH-cytochrome P450 reductase in membranes","volume":"98","author":"Backes","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.110.068478_bib4","doi-asserted-by":"crossref","first-page":"17036","DOI":"10.1074\/jbc.273.27.17036","article-title":"Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450 reductase","volume":"273","author":"Bridges","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.068478_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsbmb.2007.02.002","article-title":"Progesterone receptor membrane component 1: an integrative review","volume":"105","author":"Cahill","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/mol.110.068478_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0076-6879(91)06081-D","article-title":"Heterologous expression of mammalian P450 in COS cells","volume":"206","author":"Clark","year":"1991","journal-title":"Methods Enzymol"},{"key":"10.1124\/mol.110.068478_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/bcr2191","article-title":"PGRMC1: a new biomarker for the estrogen receptor in breast cancer","volume":"10","author":"Craven","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1124\/mol.110.068478_bib8","doi-asserted-by":"crossref","first-page":"36543","DOI":"10.1074\/jbc.M706770200","article-title":"Regulation of iron homeostasis mediated by the heme-binding protein Dap1 (damage resistance protein 1) via the P450 protein Erg11\/Cyp51","volume":"282","author":"Craven","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.068478_bib9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/1389200023337054","article-title":"The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans","volume":"3","author":"Danielson","year":"2002","journal-title":"Curr Drug Metab"},{"key":"10.1124\/mol.110.068478_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cmet.2007.01.007","article-title":"A helping hand for cytochrome p450 enzymes","volume":"5","author":"Debose-Boyd","year":"2007","journal-title":"Cell Metab"},{"key":"10.1124\/mol.110.068478_bib11","doi-asserted-by":"crossref","first-page":"36628","DOI":"10.1074\/jbc.M109.054304","article-title":"Domain motion in cytochrome P450 reductase: conformational equilibria revealed by NMR and small-angle x-ray scattering","volume":"284","author":"Ellis","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.068478_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2005.12.022","article-title":"Protein sensors for membrane sterols","volume":"124","author":"Goldstein","year":"2006","journal-title":"Cell"},{"key":"10.1124\/mol.110.068478_bib13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.pa.35.040195.002101","article-title":"Cytochromes P450 expression systems","volume":"35","author":"Gonzalez","year":"1995","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.110.068478_bib14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/EC.2.2.306-317.2003","article-title":"Saccharomyces cerevisiae Dap1p, a novel DNA damage response protein related to the mammalian membrane-associated progesterone receptor","volume":"2","author":"Hand","year":"2003","journal-title":"Eukaryot Cell"},{"key":"10.1124\/mol.110.068478_bib15","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1124\/dmd.110.034942","article-title":"CYP2C8 exists as a dimer in natural membranes","volume":"38","author":"Hu","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.110.068478_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2006.12.009","article-title":"Dap1\/PGRMC1 binds and regulates cytochrome P450 enzymes","volume":"5","author":"Hughes","year":"2007","journal-title":"Cell Metab"},{"key":"10.1124\/mol.110.068478_bib17","article-title":"Simultaneous absolute quantification of 11 cytochrome P450 isoforms in human liver microsomes by liquid chromatography tandem mass spectrometry with in silico target peptide selection","author":"Kawakami","year":"2010","journal-title":"J Pharm Sci"},{"key":"10.1124\/mol.110.068478_bib18","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.steroids.2007.12.017","article-title":"Progesterone receptor membrane component 1\u2013many tasks for a versatile protein","volume":"73","author":"L\u00f6sel","year":"2008","journal-title":"Steroids"},{"key":"10.1124\/mol.110.068478_bib19","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1128\/MCB.25.5.1669-1679.2005","article-title":"Dap1p, a heme-binding protein that regulates the cytochrome P450 protein Erg11p\/Cyp51p in Saccharomyces cerevisiae","volume":"25","author":"Mallory","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.110.068478_bib20","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1093\/hmg\/ddn274","article-title":"Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure","volume":"17","author":"Mansouri","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1124\/mol.110.068478_bib21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1432-1033.1996.0726u.x","article-title":"Purification and partial sequencing of high-affinity progesterone-binding site(s) from porcine liver membranes","volume":"239","author":"Meyer","year":"1996","journal-title":"Eur J Biochem"},{"key":"10.1124\/mol.110.068478_bib22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.mce.2008.09.017","article-title":"Genetic variation in human P450 oxidoreductase","volume":"300","author":"Miller","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/mol.110.068478_bib23","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1111\/j.1742-4658.2005.04977.x","article-title":"Molecular identification of adrenal inner zone antigen as a heme-binding protein","volume":"272","author":"Min","year":"2005","journal-title":"FEBS J"},{"key":"10.1124\/mol.110.068478_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mce.2003.11.025","article-title":"Characterization of the adrenal-specific antigen IZA (inner zone antigen) and its role in the steroidogenesis","volume":"215","author":"Min","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/mol.110.068478_bib25","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/mc.20205","article-title":"Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity","volume":"45","author":"Nie","year":"2006","journal-title":"Mol Carcinog"},{"key":"10.1124\/mol.110.068478_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-4838(00)00188-6","article-title":"Localization and topology of ratp28, a member of a novel family of putative steroid-binding proteins","volume":"1543","author":"N\u00f6lte","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/mol.110.068478_bib27","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1210\/en.2006-0114","article-title":"Progesterone membrane receptor component 1 expression in the immature rat ovary and its role in mediating progesterone\u2019s antiapoptotic action","volume":"147","author":"Peluso","year":"2006","journal-title":"Endocrinology"},{"key":"10.1124\/mol.110.068478_bib28","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1046\/j.1432-1327.2001.02096.x","article-title":"Identification of the rat adrenal zona fasciculata\/reticularis specific protein, inner zone antigen (IZAg), as the putative membrane progesterone receptor","volume":"268","author":"Raza","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1124\/mol.110.068478_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pharmthera.2008.09.006","article-title":"PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding","volume":"121","author":"Rohe","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.110.068478_bib30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuroscience.2004.04.003","article-title":"Expression and localization of 25-Dx, a membrane-associated putative progesterone-binding protein, in the developing Purkinje cell","volume":"126","author":"Sakamoto","year":"2004","journal-title":"Neuroscience"},{"key":"10.1124\/mol.110.068478_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0163-7258(02)00327-3","article-title":"The many roles of cytochrome b5","volume":"97","author":"Schenkman","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.110.068478_bib32","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1093\/carcin\/17.12.2609","article-title":"Isolation and characterization of a novel gene induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver","volume":"17","author":"Selmin","year":"1996","journal-title":"Carcinogenesis"},{"key":"10.1124\/mol.110.068478_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nmeth752","article-title":"Photo-leucine and photo-methionine allow identification of protein-protein interactions in living cells","volume":"2","author":"Suchanek","year":"2005","journal-title":"Nat Methods"},{"key":"10.1124\/mol.110.068478_bib34","doi-asserted-by":"crossref","first-page":"24327","DOI":"10.1074\/jbc.270.41.24327","article-title":"The cytoplasmic and N-terminal transmembrane domains of cytochrome P450 contain independent signals for retention in the endoplasmic reticulum","volume":"270","author":"Szczesna-Skorupa","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.068478_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/abbi.1999.1628","article-title":"Cytochromes P450 2C1\/2 and P450 2E1 are retained in the endoplasmic reticulum membrane by different mechanisms","volume":"374","author":"Szczesna-Skorupa","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/mol.110.068478_bib36","doi-asserted-by":"crossref","first-page":"14793","DOI":"10.1073\/pnas.95.25.14793","article-title":"Mobility of cytochrome P450 in the endoplasmic reticulum membrane","volume":"95","author":"Szczesna-Skorupa","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.068478_bib37","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1083\/jcb.108.4.1237","article-title":"NH2-terminal substitutions of basic amino acids induce translocation across the microsomal membrane and glycosylation of rabbit cytochrome P450IIC2","volume":"108","author":"Szczesna-Skorupa","year":"1989","journal-title":"J Cell Biol"},{"key":"10.1124\/mol.110.068478_bib38","doi-asserted-by":"crossref","first-page":"19409","DOI":"10.1074\/jbc.M002394200","article-title":"Endoplasmic reticulum retention determinants in the transmembrane and linker domains of cytochrome P450 2C1","volume":"275","author":"Szczesna-Skorupa","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.068478_bib39","doi-asserted-by":"crossref","first-page":"45009","DOI":"10.1074\/jbc.M104676200","article-title":"The juxtamembrane sequence of cytochrome P-450 2C1 contains an endoplasmic reticulum retention signal","volume":"276","author":"Szczesna-Skorupa","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.068478_bib40","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1074\/jbc.M509522200","article-title":"BAP31 is involved in the retention of cytochrome P450 2C2 in the endoplasmic reticulum","volume":"281","author":"Szczesna-Skorupa","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.068478_bib41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1517\/17425255.4.2.123","article-title":"Influence of protein-protein interactions on the cellular localization of cytochrome P450","volume":"4","author":"Szczesna-Skorupa","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/mol.110.068478_bib42","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1016\/j.yexcr.2008.08.003","article-title":"Proteasome inhibition compromises direct retention of cytochrome P450 2C2 in the endoplasmic reticulum","volume":"314","author":"Szczesna-Skorupa","year":"2008","journal-title":"Exp Cell Res"},{"key":"10.1124\/mol.110.068478_bib43","doi-asserted-by":"crossref","first-page":"31269","DOI":"10.1074\/jbc.M301489200","article-title":"Fluorescence resonance energy transfer analysis of cytochromes P450 2C2 and 2E1 molecular interactions in living cells","volume":"278","author":"Szczesna-Skorupa","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.068478_bib44","doi-asserted-by":"crossref","first-page":"27438","DOI":"10.1074\/jbc.271.44.27438","article-title":"Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4. Characterization of a reconstituted cytochrome P450 3A4\/NADPH-cytochrome P450 reductase system and studies with apo-cytochrome b5","volume":"271","author":"Yamazaki","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.068478_bib45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/prep.2001.1578","article-title":"Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli","volume":"24","author":"Yamazaki","year":"2002","journal-title":"Protein Expr Purif"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24028967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24028967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.110.068478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:50:17Z","timestamp":1739958617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24028967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0026895X24028967"],"URL":"https:\/\/doi.org\/10.1124\/mol.110.068478","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progesterone Receptor Membrane Component 1 Inhibits the Activity of Drug-Metabolizing Cytochromes P450 and Binds to Cytochrome P450 Reductase","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.110.068478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}